We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ObsEva SA | NASDAQ:OBSV | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.1018 | 0.1017 | 0.106 | 0 | 01:00:00 |
ObsEva Files Year End 2022 Financial Statements
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
GENEVA, Switzerland – March 31, 2023 – ObsEva SA (SIX: OBSN / OTC Pink Market: OBSVF), a biopharmaceutical company developing and commercializing novel therapies to improve women’s health, today published its U.S. Annual Report on Form 10-K for Fiscal Year 2022, including the U.S. GAAP financial results for year-end 2022. The U.S. Annual Report on Form 10-K can be accessed in the financial section of the Company’s website, here or directly via the link here.
ObsEva expects to publish its Swiss Annual Report to Shareholders, including the financial results for year end 2022 in IFRS, in the week commencing April 24, 2023.
About ObsEvaObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy. ObsEva has established a development program focused on improving in vitro fertilization success rates. ObsEva is listed on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN” and on the OTC Pink Market under the ticker symbol “OBSVF”. For more information, please visit www.ObsEva.com
For further information, please contact:
CEO Office contactShauna Dillonshauna.dillon@obseva.ch+41 22 552 1550
Investor ContactWill Brownwill.brown@obseva.com +1 (334) 313-2319
###
Attachment
1 Year ObsEva Chart |
1 Month ObsEva Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions